scout
|Articles|March 23, 2015

Special Reports

  • Immunotherapy (Issue 5)
  • Volume 5
  • Issue 1

Immunotherapy in GU Cancers

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

<<<

View the entire Special Report on Immunotherapy

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME